Four tiers. Use what you need.

Same model as a modern API platform — try free, pay-as-you-go for production, subscribe for enterprise, share IP for co-development. Pricing reflects our launch model: the Explorer demo is live today; Professional, Enterprise, and Co-development engagements are onboarding design partners now, not yet generally available. Prices below are indicative. No procurement-heavy enterprise sales for small teams; no public price list for partnerships that should be conversations.

Explorer
Free
Try the platform. For academics, students, and evaluators.
  • ESMFold + public Library slice
  • 5 design requests / month
  • Public targets only
  • Email support
No card required
Enterprise
$50K–500K / yr
Annual subscription. Custom models. SLA. Private deployment.
  • Usage quota included
  • Custom fine-tuning on your data
  • Dedicated technical contact
  • SLA + private support channel
  • Optional VPC deployment
  • SOC 2 Type I planned (Phase 2 roadmap); Type II to follow
Mid-cap to big-pharma
Co-development
IP-share
$0 upfront. Share the candidate. We share the risk.
  • Full platform access for the program
  • Co-owned candidate IP — allocation structure negotiated per engagement
  • $1–3M at IND, $5–10M at Ph2, $10–20M at approval (platform-contribution component; acquirer/approval milestones set per full deal economics)
  • Milestone ranges are indicative of industry norms; actual terms set per engagement.
  • Low single-digit royalty on net sales
  • 5-year time-cap; no zombie deals
  • Capped at 3–5 partners
For pre-Series-A biotechs with target insight but no platform

All prices in USD. Quantum-job pricing is indicative — quantum hardware is not yet in production use; when live, quantum jobs will be priced at hardware pass-through + modest margin (no opaque markup on IBM Quantum or Quantinuum fees). Usage-based billing handled via Stripe Metering; invoices monthly. Forward-looking statements (timelines, milestones, roadmap, pricing) are estimates, not commitments, and nothing here is an offer to sell or a solicitation to buy securities. Questions →